Pasadena Private Wealth LLC decreased its position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Free Report) by 5.1% during the 2nd quarter, Holdings Channel reports. The fund owned 13,685 shares of the real estate investment trust’s stock after selling 731 shares during the quarter. Pasadena Private Wealth LLC’s holdings in Sabra Healthcare REIT were worth $252,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also bought and sold shares of SBRA. SVB Wealth LLC acquired a new stake in Sabra Healthcare REIT during the 1st quarter worth approximately $34,000. Wealth Preservation Advisors LLC acquired a new stake in Sabra Healthcare REIT during the 1st quarter worth approximately $38,000. Northwestern Mutual Wealth Management Co. raised its holdings in Sabra Healthcare REIT by 61.2% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 2,806 shares of the real estate investment trust’s stock worth $49,000 after buying an additional 1,065 shares during the period. Anchor Investment Management LLC acquired a new stake in Sabra Healthcare REIT during the 1st quarter worth approximately $58,000. Finally, Assetmark Inc. raised its holdings in Sabra Healthcare REIT by 37.8% during the 1st quarter. Assetmark Inc. now owns 3,607 shares of the real estate investment trust’s stock worth $63,000 after buying an additional 989 shares during the period. Institutional investors own 99.40% of the company’s stock.
Wall Street Analyst Weigh In
Several analysts have commented on SBRA shares. JMP Securities raised their target price on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a “market outperform” rating in a report on Wednesday, August 6th. National Bankshares set a $22.00 target price on shares of Sabra Healthcare REIT in a report on Friday, October 17th. Cantor Fitzgerald started coverage on shares of Sabra Healthcare REIT in a report on Wednesday, October 1st. They set a “neutral” rating and a $20.00 target price on the stock. Weiss Ratings restated a “buy (b)” rating on shares of Sabra Healthcare REIT in a report on Saturday. Finally, Wells Fargo & Company lowered their price objective on shares of Sabra Healthcare REIT from $21.00 to $20.00 and set an “overweight” rating on the stock in a report on Tuesday, October 21st. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Sabra Healthcare REIT has an average rating of “Moderate Buy” and an average price target of $20.75.
Sabra Healthcare REIT Price Performance
NASDAQ SBRA opened at $18.08 on Monday. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91. Sabra Healthcare REIT, Inc. has a 12-month low of $15.60 and a 12-month high of $20.03. The company has a market capitalization of $4.34 billion, a PE ratio of 23.79, a price-to-earnings-growth ratio of 1.15 and a beta of 0.85. The firm’s 50 day moving average is $18.65 and its 200-day moving average is $18.24.
Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.36 by $0.02. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The company had revenue of $189.15 million for the quarter, compared to the consensus estimate of $185.64 million. During the same period last year, the company earned $0.36 earnings per share. The firm’s revenue was up 7.4% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. Equities research analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.
Sabra Healthcare REIT Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Friday, August 15th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 6.6%. The ex-dividend date was Friday, August 15th. Sabra Healthcare REIT’s payout ratio is presently 157.89%.
Sabra Healthcare REIT Profile
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Read More
- Five stocks we like better than Sabra Healthcare REIT
- How to Plot Fibonacci Price Inflection Levels
- PulteGroup Is Down But Not Out—Here’s What Wall Street Missed
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Cleveland-Cliffs Breaks to New Highs on Earnings, More Upside?
- The 3 Best Retail Stocks to Shop for in August
- Is Landstar the Next Big Winner in Transportation Stocks?
Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Free Report).
Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
